Male preponderance of patients testing positive for malignant hyperthermia susceptibility

Acta Anaesthesiologica Scandinavica

Volumn 51, Issue 5, 2007, Pages 614-620

  Islander, G ^a   Rydenfelt, K ^a   Ranklev, E ^a   Bodelsson, M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diagnosis; In vitro contracture test; Malignant hyperthermia; Sex factors

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; IN VITRO CONTRACTURE TEST; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTHERMIA; PRIORITY JOURNAL; RELATIVE; SEX DIFFERENCE; SWEDEN;

CAFFEINE; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HALOTHANE; HUMANS; MALE; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; MUTATION; REGISTRIES; RESEARCH DESIGN; SEX FACTORS; STATISTICS, NONPARAMETRIC; SWEDEN;

EID: 34147156734     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01293.x     Document Type: Article

References (31)

1. Gronert G, Pessah I, Muldoon S, Tautz T. Malignant hyperthermia. In: Miller R, ed. Miller's Anesthesia. Philadelphia, PA: Elsevier/Churchill Livingstone, 2005: 1169-90.
2. Ørding H, Brancadoro V, Cozzolino S et al. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 1997; 41: 955-66.
3. European MH Group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984; 56: 1267-9.
4. Urwyler A, Deufel T, McCarthy T, West S. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001; 86: 283-7.
5. Broman M, Islander G, Müller CR, Ranklev-Twetman E. Malignant hyperthermia and central core disease causative mutations in Swedish patients. Acta Anaesthesiol Scand 2007; 51: 50-3.
6. Online Mendelian Inheritance in Man, OMIM (TM). Baltimore, MD: John Hopkins University, 2006: MIM number {#145600}. URL http://www.ncbi.nlm. nih.gov/omim/ [accessed on 23 March 2006].
7. Rueffert H, Olthoff D, Deutrich C et al. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations. Acta Anaesthesiol Scand 2002; 46: 692-8.
8. Urwyler A, Halsall PJ, Mueller C et al. Ryanodine receptor gene (RYR1) mutations for diagnosing susceptibility to malignant hyperthermia. Acta Anaesthesiol Scand 2003; 47: 492.
9. Rueffert H, Olthopp D. Authors reply. Acta Anaesthesiol Scand 2003; 47: 493.
10. Ball SP, Johnson KJ. The genetics of malignant hyperthermia. J Med Genet 1993; 30: 89-93.
11. Nussbaum R, McInnes R, Willard H. Thompson and Thompson Genetics in Medicine, 6th edn. Philadelphia, PA: Saunders/ Elsevier, 2004.
12. Denborough MA, Forster JF, Lovell RR, Maplestone PA. Anaesthetic deaths in a family. Br J Anaesth 1962; 34: 395-6.
13. Halsall J, Robinson R. Genetic testing for malignant hyperthermia. Curr Anaesth Crit Care 2004; 15: 11-21.
14. Robinson R, Hopkins P, Carsana A et al. Several interacting genes influence the malignant hyperthermia phenotype. Hum Genet 2003; 112: 217-8.
15. Islander G, Bendixen D, Ranklev-Twetman E, Ørding H. Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands. Acta Anaesthesiol Scand 1996; 40: 579-84.
16. Robinson RL, Curran JL, Ellis FR et al. Multiple interacting gene products may influence susceptibility to malignant hyperthermia. Ann Hum Genet 2000; 64: 307-20.
17. Ørding H. Investigation of malignant hyperthermia susceptibility in Denmark. Dan Med Bull 1996; 43: 111-25.
18. Kikuchi H, Morio M, Shinozaki M, Ishihara S. Statistical considerations of malignant hyperthermia in Japan. In: Aldrete, JA, Britt, BA, eds. Second International Symposium on Malignant Hyperthermia. New York: Grune & Stratton, 1978: 483-98.
19. Larach ML, Localio AR, Allen GC. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771-9.
20. Guyton A, Hall J. Textbook of Medical Physiology, 10th edn. Philadelphia, PA: W.B. Saunders, 2000.
21. Chu SH, Sutherland K, Beck J, Kowalski J, Goldspink P, Schwertz D. Sex differences in expression of calcium-handling proteins and beta-adrenergic receptors in rat heart ventricle. Life Sci 2005; 76: 2735-49.
22. Pavlovic M, Schaller A, Steiner B et al. Gender modulates the expression of calcium-regulating proteins in pediatric atrial myocardium. Exp Biol Med 2005; 230: 853-9.
23. 2+-handling in failing human myocardium. J Mol Cell Cardiol 2001; 33: 1345-53.
24. Verkerk AO, Wilders R, Veldkamp MW, de Geringel W, Kirkels JH, Tan HL. Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes. Int Heart J 2005; 46: 1105-18.
25. Johnson BD, Zheng W, Korach KS, Scheuer T. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol 1997; 110: 135-40.
26. Wiik A, Glenmark B, Ekman M, Esbjornsson-Liljedahl M. Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol Scand 2003; 179: 381-7.
27. Pleym H, Spigset O, Kharasch ED, Dale O. Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand 2003; 47: 241-59.
28. Isaacs H, Badenhorst M. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia. Anesthesiology 1993; 79: 5-9.
29. Wedel DJ, Nelson TE. Malignant hyperthermia - diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone. Anesth Analg 1994; 78: 787-92.
30. Online Mendelian Inheritance in Man, OMIM (TM). Baltimore, MD: John Hopkins University, 2006: MIM number {#117000}. URL http://www.ncbi.nlm. nih.gov/omim/ [accessed on 12 June 2006].
31. Robinson RL, Brooks C, Brown SL et al. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mutat 2002; 20: 88-97.